# Effects of Ondansetron in Obsessive-compulsive and Tic Disorders

> **NCT03239210** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 110 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder
- Tic Disorders
- Tourette Syndrome

## Interventions

- **DRUG:** Ondansetron
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03239210
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-16
- **Primary completion:** 2022-05-16
- **Final completion:** 2022-05-16
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2024-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03239210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03239210, "Effects of Ondansetron in Obsessive-compulsive and Tic Disorders". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03239210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*